SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): May 5, 2004 (May 5, 2004)
ENDO PHARMACEUTICALS HOLDINGS INC.
(Exact name of registrant as specified in its charter)
| | | | |
| DELAWARE | | 001-15989 | | 13-4022871 |
|
(State or other
jurisdiction of
incorporation) | | (Commission File Number) | | (I.R.S. Employer
Identification No.) |
| | | | | |
100 Painters Drive
Chadds Ford, Pennsylvania | | | 19317 | |
|
| (Address of principal executive offices) | | (Zip Code) |
(610) 558-9800
(Registrant’s telephone number, including area code)
N/A
(Former name or former address, if changed since last report)
TABLE OF CONTENTS
Item 7. Financial Statements and Exhibits.
| (a) | | Financial Statements of Business Acquired. |
Not applicable.
| (b) | | Pro Forma Financial Information. |
Not applicable.
| | | |
Exhibit Number
| | Description
|
| 99.1 | | Slide Presentation of Endo Pharmaceuticals Holdings Inc. dated May 5, 2004 |
Item 9. Regulation FD Disclosure.
On May 5, 2004, the Registrant intends to make a slide presentation at theSmith Barney Citigroup Small & Mid-Cap Conferencein Las Vegas, Nevada, a copy of which presentation is filed herewith as Exhibit 99.1 and is incorporated herein by reference.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
| | | | | |
| | | ENDO PHARMACEUTICALS HOLDINGS INC. |
| | | (Registrant) |
| | | | | |
| | By: | | /s/ CAROL A. AMMON |
| | | |
|
| | | | Name: Carol A. Ammon |
| | | | Title: Chairman & Chief Executive Officer |
| | | | | |
| Dated: May 5, 2004 | | | | |
INDEX TO EXHIBITS
| | | |
Exhibit No.
| | Description
|
| 99.1 | | Slide Presentation of Endo Pharmaceuticals Holdings Inc. dated May 5, 2004 |
